Inventor

Alan F. Wahl

Inventor
Mercer Island, WA, US

Overview

20→
Patents
2005–2019
Patent span
Human necessities
Primary field (CPC A)

Patents· 20 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes34%
C07KPeptides34%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
PatentTitleYear
10,233,258Bispecific binding proteins that bind CD40 and mesothelin20199,345,785'Treatment of renal cell carcinoma with anti-CD70 antibody-drug conjugates'20169,051,372'Anti-CD70 antibody and its use for the treatment of cancer and immune disorders'20158,647,624'Treatment of immune disorders with anti-CD70 antibody'20148,609,104'Treatment of B-cell cancers with anti-CD70 antibody-drug conjugates'20138,535,678'Anti-CD70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders'20138,512,707'Methods of treating drug-resistant cancers'20138,337,838'Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders'20127,824,683'Methods for augmenting an immune response using anti-CD40 antibodies'20107,695,716'Methods of treating neoplastic, autoimmune and inflammatory diseases'20107,666,422'Methods for the treatment of cancer using anti-CD40 antibodies'20107,662,387'Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders'20107,641,903'Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders'20107,510,711'Methods for the treatment of cancer using anti-CD40 antibodies'20097,498,032'Methods for treating immune disorders or cancer with anti-CD40 antibodies'20097,491,390'Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders'20097,090,843'Recombinant anti-CD30 antibodies and uses thereof'20066,946,129'Recombinant anti-CD40 antibody and uses thereof'20056,843,989'Methods for the treatment and prevention of cancer using anti-CD40 antibodies'20056,838,261'Nucleic acids encoding anti-CD40 proteins and methods of producing recombinant anti-CD40 proteins'2005

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2005–2016Patents assigned to SEATTLE GENETICS INC (18)· patent assignee history
2005–2016Based in Mercer Island, WA, US· patent location history
2010–2014Based in Bothell, WA, US· patent location history
2012–2016Patents assigned to WAHL ALAN F (7)· patent assignee history
2012–2016Patents assigned to LAW CHE-LEUNG (6)· patent assignee history
2012–2015Patents assigned to MCEARCHERN JULIE (3)· patent assignee history
2013–2016Patents assigned to PESTANO LINDA A (3)· patent assignee history
2019Based in Del Mar, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SEATTLE GENETICS INC182005–2016
WAHL ALAN Fself72012–2016
LAW CHE-LEUNG62012–2016
MCEARCHERN JULIE32012–2015
PESTANO LINDA A32013–2016
Locations
LocationPatentsSpan
Mercer Island, Washington, US172005–2016
Bothell, Washington, US22010–2014
Del Mar, California, US12019